logo

iStock Rating

F
Details...
Enter Symbol click to research

AtheroGenics, Inc. (NASDAQ: AGIX)

Sector: Medical

Current Price : $0.07

52 Week Low
$0.0752 Week High
$1.86
 

ATHEROGENI(NSDQ:AGIX)
AtheroGenics is an emerging pharmaceutical company focused on thediscovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as asthma. The company has designed its lead product candidate, AGI-1067, as an oral drug to benefit patients with coronary artery disease. The company has combined its basic research in the role of blood vessels in inflammation with applied research techniques into an integrated process to discover new drugs for treating diseases of chronic inflammation.
# Employees: 57
Address: 8995 Westside Parkway,Alpharetta,GA,USA
Phone: 678 336-2500
Fax: 678 336-2501
Website: www.atherogenics.com
Email: investor@atherogenics.com
Sector: Medical
Industry: MED-DRUGS
Executive Officers
Russell M. Medford (Presi.; C.E.O.; Dir.)
Mark P. Colonnese (Exec. V.P. Commercial Oper.; C.F.O.)
Charles A. Deignan (V.P. Fin. & Admn. & Princ. Acctg. Off.)
David Bearman (Dir.)
Vaughn D. Bryson (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 6/30/2008
Next Earnings Date(Expected): 10/23/2008
Mean EPS (Next Qtr): ($0.20)
Mean EPS (Year): ($1.30)
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 2
Shares Performance
Period agix Compare to S&P
YTD -81.58 % -67.77 %
4 Weeks -82.05 % -78.66 %
12 Weeks -89.06 % -86.26 %
Shares Information
Analyst Coverage: Y
Avg Volume: 1084804
Shares Outstanding: 39M
Market Cap: $0.00B
52 Week High: $1.86
52 Week Low: $0.07
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 1/1/1990 agix split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 5.26 %
EPS Growth in Last Year: -125.00 %
Sales Growth in Last Quarter: -0.01 %
Sales Growth in Last Quarter: -100.00 %
Financials
Qtr Book Value: ($0.01)
Cash Flow/Share: ($0.01)
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Home | Login |Research | Earnings | Scans | Charts | Submit Article | Join Blog Network | Advertise | Subscribe to RSS

Terms of Use | Privacy Policy | Copyright 2012 all rights reserved
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.